Skip to main content
Chi Dang, MD, Oncology, Philadelphia, PA

ChiVanDangMDPhD

Oncology • Philadelphia, PA

Director, Abramson Cancer Center; Professor, Medicine, Perelman School of Medicine

Join to view full profile

Dr. Dang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Dang's full profile

Already have an account?

  • Office

    3400 Civic Center Blvd
    Philadelphia, PA 19104
    Phone+1 215-615-5858

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1985 - 1987
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1983 - 1985
  • Johns Hopkins University
    Johns Hopkins UniversityInternship, Internal Medicine, 1982 - 1983
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1982

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2012 - 2021
  • MD State Medical License
    MD State Medical License 1982 - 2012

Awards, Honors, & Recognition

  • Member, Institute of Medicine National Academy of Sciences
  • Fellow American Academy of Arts & Sciences

Publications & Presentations

PubMed

Press Mentions

  • Study Shows Chemotherapy-Resistant Neuroblastoma Cells Have More Active Inflammatory Sensing and Signaling
    Study Shows Chemotherapy-Resistant Neuroblastoma Cells Have More Active Inflammatory Sensing and SignalingFebruary 8th, 2022
  • Potential Tumor Vulnerability May Be Exploited to Improve Treatment of Neuroblastoma
    Potential Tumor Vulnerability May Be Exploited to Improve Treatment of NeuroblastomaFebruary 7th, 2022
  • Ludwig Cancer Research Welcomes Mikaël Pittet to Ludwig Lausanne
    Ludwig Cancer Research Welcomes Mikaël Pittet to Ludwig LausanneAugust 4th, 2021
  • Join now to see all

Grant Support

  • Defining metabolic adaptations within the PDAC "arid" tumor microenvironmentJOHNS HOPKINS UNIVERSITY2021–2026
  • Defining the Role of the Cancer Circadian Clock in Tumor Immunity and TumorigenesisJOHNS HOPKINS UNIVERSITY1990–2025

Dr. Chi Dang, Dr. Chi Dang, MD, Dr. C Dang, Dr. Chi Van Dang